Direct targeting of Capza1 by silibinin

Exploratory Score: 0.850 Price: $0.50 breast cancer MCF-7 and MDA-MB-231 human breast cancer cell lines Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting CAPZA1, YAP1 in MCF-7 and MDA-MB-231 human breast cancer cell lines. Primary outcome: Direct drug-protein interaction and F-actin disassembly

Description

This experiment focused on identifying the direct molecular target of silibinin that mediates F-actin disassembly. The researchers used biochemical approaches to investigate the interaction between silibinin and F-actin regulatory proteins. They discovered that silibinin directly targets Capza1 (capping actin protein of muscle Z-line subunit alpha 1), which is responsible for F-actin disassembly. The study likely employed techniques such as CETSA (cellular thermal shift assay) and DARTS (drug affinity responsive target stability) to demonstrate direct drug-protein interactions. The researchers showed that Capza1-mediated F-actin disassembly is the decisive mechanism for silibinin-induced cell cycle arrest, even when YAP activity is modulated. This experiment revealed a positive feedback loop between YAP and F-actin, where promoting F-actin assembly through si-Capza1 transfection can restore YAP activity.

TARGET GENE
CAPZA1, YAP1
MODEL SYSTEM
MCF-7 and MDA-MB-231 human breast cancer cell lines
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
actin cytoskeleton organization, actin capping
SOURCE
extracted_from_pmid_41349910
PRIMARY OUTCOME
Direct drug-protein interaction and F-actin disassembly

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

YAP1 — Yes-Associated Protein 1geneYAP1 ProteinproteinYAP/TEAD Pathway Modulators for NeurodegenerationtherapeuticYAP/TAZ Mechanoactivation Protocol for NeurodegeneideaYAP/TAZ (Hippo) Signaling in NeurodegenerationmechanismYAP/TAZ Signaling Pathway in NeurodegenerationmechanismCancerdiseaseResearchersindexHippo Signaling in 4R-TauopathiesmechanismHippo Signaling Pathway in Parkinson's Diseasemechanism

Protocol

CETSA, DARTS, protein-drug interaction assays, siRNA transfection, F-actin visualization, YAP activity assessment

Expected Outcomes

Expected to identify direct molecular target of silibinin; found Capza1 as the primary target mediating F-actin disassembly

Success Criteria

Demonstration of direct silibinin-Capza1 interaction and rescue of phenotype by Capza1 knockdown

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.